• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
EMD

EMYRIA LIMITED - Charts / Financials

8.89% ! 4.9¢
Market Cap $32.54M  !
Healthcare Biotechnology
Add to My Watchlist

Emyria Limited is an Australia-based early-stage drug development company. The Company is... Emyria Limited is an Australia-based early-stage drug development company. The Company is focused on delivering and developing treatments for mental health and select neurological conditions, guided by real-world data collected with patients across its wholly owned clinical service subsidiaries. Its pipeline comprises MDMA analogue drug development and commercialization of novel serotonin-releasing agents. Its Emyria Healthcare provides evidence-based treatment for patients not finding relief from conventional care, while also helping evaluate emerging new therapies like assisted therapy for post-traumatic stress disorder (PTSD) and assisted therapy for treatment-resistant depression. Its Emyria Data is a robust and ethically sourced real-world data gathered with patients and used to improve its therapy and drug development programs. Its Emyria’s Pipeline includes new psychedelic-assisted therapies and drug treatments for mental health and select neurological diseases.More

refresh Created with Sketch. REFRESH
Last update - 15.58pm 03/09/2025 (20 minute delay) ?
Day
Open 4.6¢   Day High 5.0¢   Day Low 4.5¢
Daily Volume 6186144
Bids   Sellers
Number Price Volume   Number Price Volume
2 4.8¢ 103716   5 5.0¢ 1332233

Directors & Senior Management

Dr. Michael Gordon Winlo Managing Director
Ms. Susan Park Company Secretary
Mr. Greg Hutchinson Independent Non-Executive Chairman of the Board
Dr. Mohit Kaushal Non-Executive Director
Dr. Karen L. Smith Non-Executive Director
Prof. Sir John Tooke Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.9¢ 		Change
0.004(8.89%) 		Mkt cap ! $32.54M
Open High Low Value Volume
4.6¢ 5.0¢ 4.5¢ $292.5K 6.186M

Buyers (Bids)

No. Vol. Price($)
2 103716 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 1332233 5
View Market Depth
Last trade - 15.47pm 03/09/2025 (20 minute delay) ?
Last
4.9¢ 		  Change
0.004 ( 6.52 %)
Open High Low Volume
4.5¢ 5.0¢ 4.5¢ 918354
Last updated 15.58pm 03/09/2025 ?

Top Stories

ABX Group joins top gainers board as ANSTO REE testwork prompts conviction

ABX Group has seen shares pop no less than +107% after Australia's nuclear regulator ANTSO confirmed "high extractions of heavy rare earths."
Lithium plays are getting into gold. But this uranium stock's getting into REEs, antimony Energy nanocap Terra Uranium has jumped nearly +14% in afternoon trades to nearly 7cps, which brings its one-month gains to +120%.
Listen: HotCopper Wire Podcast 023 – Glowing gold, shining silver, and... wheat collusion? In this HotCopper Wire episode, we look at surging gold and silver as well as Trump's appeals court clash, and a wheat futures conspiracy.
Market Close: ASX at 3-week lows, but Wall Street futures green Weds arvo Good Afternoon and welcome to HotCopper’s Market Close for Wednesday, I’m Jon Davidson. The market hit three week lows this week as Wall Street proves to be a wet blanket kicking off September; not helping matters, hotter than expected Aussie GDP showing a resilien...
AGC delivers strong near-surface gold hits at Achilles AGC chief Diemar unpacks Australian Gold and Copper's outstanding near-surface gold and silver results at its Achilles discovery.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.